Pfizer

COVID-19 Pfizer/BioNTech booster approved by FDA and CDC

The plan to offer Americans a third, booster shot of the Pfizer/BioNTech COVID-19 vaccine has finally been waved through by the FDA and CDC. ... The FDA’s decision to extend the emergency use authorisation (EUA) for Pfizer’s Comirnaty vaccine comes

AstraZeneca invests in RNA tech platform

After decades of research and many frustrating setbacks, RNA technology is finally having its moment in the sun as Pfizer and Moderna COVID-19 vaccines spread immunity across the globe.

UK announces COVID boosters for a “bumpy winter” ahead

A single shot of Pfizer’s COVID-19 vaccine will be offered to 30 million people in the UK including those 50 or over and frontline health and social care workers. ... protection. The JCVI advice is based on trials that have been carried out in the UK,

Are healthcare brands finally wising up to the power of creative-led communications?

And the list goes on. So it seems, encouragingly, that health and pharma brands – from Pfizer to Teva and Roche Genentech to Janssen – seem to finally be recognising the power of

Pfizer starts RSV trial ahead of winter season

A vaccine against the common respiratory syncytial virus could be available soon, as Pfizer joins GSK and J&J in launching phase 3 trials. ... Last week, Pfizer announced the start of a phase 3 trial for its new RSV bivalent prefusion F (RSVpreF) subunit

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]